Functional near-infrared spectroscopy (fNIRS) is an optical brain monitoring technique which uses near-infrared spectroscopy for the purpose of functional neuroimaging. Using fNIRS, brain activity is measured by using near-infrared light to estimate cortical hemodynamic activity which occur in response to neural activity. Alongside EEG, fNIRS is one of the most common non-invasive neuroimaging techniques which can be used in portable contexts. The signal is often compared with the BOLD signal measured by fMRI and is capable of measuring changes both in oxy- and deoxyhemoglobin concentration, but can only measure from regions near the cortical surface. fNIRS may also be referred to as Optical Topography (OT) and is sometimes referred to simply as NIRS. Description fNIRS estimates the concentration of hemoglobin from changes in absorption of near infrared light. As light moves or propagates through the head, it is alternately scattered or absorbed by the tissue through which it travels. Because hemoglobin is a significant absorber of near-infrared light, changes in absorbed light can be used to reliably measure changes in hemoglobin concentration. Different fNIRS techniques can also use the way in which light propagates to estimate blood volume and oxygenation. The technique is safe, non-invasive, and can be used with other imaging modalities. fNIRS is a non-invasive imaging method involving the quantification of chromophore concentration resolved from the measurement of near infrared (NIR) light attenuation or temporal or phasic changes. The technique takes advantage of the optical window in which (a) skin, tissue, and bone are mostly transparent to NIR light (700–900 nm spectral interval) and (b) hemoglobin (Hb) and deoxygenated-hemoglobin (deoxy-Hb) are strong absorbers of light. There are six different ways for infrared light to interact with the brain tissue: direct transmission, diffuse transmission, specular reflection, diffuse reflection, scattering, and absorption. fNIRS focuses primarily on absorption: differences in the absorption spectra of deoxy-Hb and oxy-Hb allow the measurement of relative changes in hemoglobin concentration through the use of light attenuation at multiple wavelengths. Two or more wavelengths are selected, with one wavelength above and one below the isosbestic point of 810 nm—at which deoxy-Hb and oxy-Hb have identical absorption coefficients. Using the modified Beer-Lambert law (mBLL), relative changes in concentration can be calculated as a function of total photon path length. Typically, the light emitter and detector are placed ipsilaterally (each emitter/detector pair on the same side) on the subject's skull so recorded measurements are due to back-scattered (reflected)